Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for TriSalus Life Sciences (TLSI) over the last 3 years, with Q3 2025 value amounting to 3.31%.

  • TriSalus Life Sciences' Return on Invested Capital fell 562300.0% to 3.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.31%, marking a year-over-year decrease of 562300.0%. This contributed to the annual value of 2.34% for FY2024, which is 17600.0% up from last year.
  • TriSalus Life Sciences' Return on Invested Capital amounted to 3.31% in Q3 2025, which was down 562300.0% from 6.09% recorded in Q2 2025.
  • TriSalus Life Sciences' 5-year Return on Invested Capital high stood at 52.92% for Q3 2024, and its period low was 6.09% during Q2 2025.
  • Moreover, its 3-year median value for Return on Invested Capital was 1.81% (2024), whereas its average is 8.45%.
  • In the last 5 years, TriSalus Life Sciences' Return on Invested Capital soared by 523400bps in 2024 and then plummeted by -562300bps in 2025.
  • Over the past 3 years, TriSalus Life Sciences' Return on Invested Capital (Quarter) stood at 5.86% in 2023, then soared by 381bps to 28.19% in 2024, then plummeted by -112bps to 3.31% in 2025.
  • Its Return on Invested Capital was 3.31% in Q3 2025, compared to 6.09% in Q2 2025 and 9.82% in Q1 2025.